Top

Published in:

01-02-2014 | Head and Neck Oncology

Postoperative Nomograms Predictive of Survival After Surgical Management of Malignant Tumors of the Major Salivary Glands

Authors: Safina Ali, MD, Frank L. Palmer, BA, Changhong Yu, MS, Monica DiLorenzo, BA, Jatin P. Shah, MD, Michael W. Kattan, PhD, Snehal G. Patel, MD, Ian Ganly, MD

Published in: Annals of Surgical Oncology | Issue 2/2014

Abstract

Objectives

The objective of this study was to create a nomogram predictive of survival in salivary gland cancer.

Methods

Clinical, tumor, and treatment characteristics were collected for 301 patients who underwent surgery for salivary gland cancer between 1985 and 2009 at Memorial Sloan Kettering Cancer Centre. Factors predictive of overall survival (OS) and cancer-specific survival (CSS) were determined by univariate analysis. Cox risk regression was used to model OS data. Competing risks regression was used for cancer-specific death. Deaths from other causes were treated as competing risks for cancer-specific death. Predictive nomograms for OS and CSS were then created using stepdown method to select predictors of outcome.

Results

The median age was 62 (range 9–89) years. There were 156 (52 %) males and 145 (48 %) females. Five variables predictive for OS (age, clinical T4 stage, histological grade, perineural invasion, and tumor dimension) were used to generate a parsimonious model, and a nomogram was created to predict 10-year survival probability. The concordance index (CI) for this nomogram was 0.809. Five variables predictive for CSS (histological grade, perineural invasion, clinical T4 stage, positive nodal status, and status of margins) were used to generate a second nomogram predicting CSS. This nomogram had a CI of 0.856. Both nomograms were validated internally by assessing discrimination and calibration.

Conclusions

We have developed the first nomograms to predict prognosis in an individual patient with salivary gland cancer.

Available only for authorised users

Spitz MR, Batsakis JG. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984;110(1):45–9.PubMedCrossRef

Barnes LEJ, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. Lyon: World Health Organization Classification of Tumours: IARC Press; 2005.

Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol. 2003;21(1):3–7.PubMedCrossRef

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.PubMedCrossRef

Kattan MW, Marasco J. What is a real nomogram? Semin Oncol. 2010;37(1):23–6.PubMedCrossRef

Kattan MW. Nomograms. Introduction. Semin Urol Oncol. 2002;20(2):79–81.PubMed

Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer. 1997;79(3):528–37.PubMedCrossRef

Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13(2):111–6.PubMedCrossRef

Lee HS, Kim SW, Kim BH, et al. Predicting nonsentinel lymph node metastasis using lymphoscintigraphy in patients with breast cancer. J Nucl Med. 2012;53(11):1693–700.PubMedCrossRef

10.

Gross ND, Patel SG, Carvalho AL, et al. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck. 2008;30(10):1352–60.PubMedCrossRef

11.

Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005;12(8):654–9.PubMedCrossRef

12.

Marko NF, Xu Z, Gao T, Kattan MW, Weil RJ. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models. Cancer. 2012;118(15):3749–57.PubMedCrossRef

13.

Ross PL, Gerigk C, Gonen M, et al. Comparisons of nomograms and urologists’ predictions in prostate cancer. Semin Urol Oncol. 2002;20(2):82–8.PubMedCrossRef

14.

Kawachi MH, Bahnson RR, Barry M, et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Cancer Netw. 2010;8(2):240–62.

15.

van Buuren S. Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3):1–67.

16.

Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG. A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res. 2011;171(1):151–8.

17.

Boukheris H, Curtis RE, Land CE, Dores GM. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2899–906.PubMedCentralPubMedCrossRef

18.

Fe H. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis: New York: Springer; 2001.

19.

Fine JP and Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94:496–509.CrossRef

20.

Barlin JN, Yu C, Hill EK, et al. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecol Oncol. 2012;125(1):25–30.PubMedCrossRef

21.

Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.PubMedCrossRef

22.

Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23(28):7005–12.PubMedCentralPubMedCrossRef

23.

Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293–8.PubMedCrossRef

Title: Postoperative Nomograms Predictive of Survival After Surgical Management of Malignant Tumors of the Major Salivary Glands
Authors: Safina Ali, MD
Frank L. Palmer, BA
Changhong Yu, MS
Monica DiLorenzo, BA
Jatin P. Shah, MD
Michael W. Kattan, PhD
Snehal G. Patel, MD
Ian Ganly, MD
Publication date: 01-02-2014
Publisher: Springer US
Published in: Annals of Surgical Oncology / Issue 2/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-013-3321-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Postoperative Nomograms Predictive of Survival After Surgical Management of Malignant Tumors of the Major Salivary Glands

Abstract

Objectives

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2014

Comparisons of Sixth and Seventh Edition of the American Joint Cancer Committee Staging Systems for Esophageal Cancer

Perioperative Antimicrobial Prophylaxis for Intra-abdominal Surgery in Patients with Cancer: A Retrospective Study Comparing Ertapenem and Nonertapenem Antibiotics

Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype

Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites

The Number of Lymph Nodes Dissected in Breast Cancer Patients Influences the Accuracy of Prognosis

Postmastectomy Radiation and Recurrence Patterns in Breast Cancer Patients Younger Than Age 35 Years: A Population-Based Cohort